Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Hepatology International|April 13, 2011
Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinomaSadahisa Ogasawara, Fumihiko Kanai, Shuntaro Obi, et al.
Liver Cancer|December 5, 2019
Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS TrialMasatoshi Kudo, Kazuomi Ueshima, Yasutaka Chiba, et al.
Journal of Hepatology|April 24, 2012
Increased activity of serum mitochondrial isoenzyme of creatine kinase in hepatocellular carcinoma patients predominantly with recurrenceYoko Soroida, Ryunosuke Ohkawa, Hayato Nakagawa, et al.
Journal of Gastroenterology|March 23, 2012
Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinomaKoji Uchino, Shuntaro Obi, Ryosuke Tateishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 10, 2012
Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 updateShuichi Kaneko, Junji Furuse, Masatoshi Kudo, et al.
Hepatology International|April 8, 2025
Hepatic immune-related adverse event increased the overall survival of patients with malignancies treated with immune checkpoint inhibitorsKaori Matsumoto, Tatsuo Kanda, Junichiro Wakatsuki, et al.
The Lancet. Gastroenterology & Hepatology|April 11, 2018
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trialMasatoshi Kudo, Kazuomi Ueshima, Osamu Yokosuka, et al.
Liver Cancer|October 21, 2020
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular CarcinomaKazuomi Ueshima, Sadahisa Ogasawara, Masafumi Ikeda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 30, 2004
A novel display of reconstruction computed tomography for the detection of small hepatocellular carcinomaTakuma Teratani, Haruhiko Yoshida, Yoshida Haruhiko, et al.
Journal of Gastroenterology|August 24, 2016
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trialMasatoshi Kudo, Etsuro Hatano, Shinichi Ohkawa, et al.
Pageof 7